SEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at Targeted Protein Degradation Think Tank Symposium
BYSI Stock | USD 1.89 0.04 2.16% |
Under 63% of all BeyondSpring's traders are looking to take a long position. The analysis of the overall investor sentiment regarding BeyondSpring suggests that some traders are interested. BeyondSpring's investing sentiment shows overall attitude of investors towards BeyondSpring.
BeyondSpring |
NEW YORK, Oct. 26, 2023 -- SEED Therapeutics Inc. , a biotech company focused on harnessing and engineering Molecular Glues for targeted protein degradation of disease-causing proteins, announced at its Monday, October 23, 2023 Targeted Protein Degradation Think Tank symposium that it had successfully discovered a ST-00937, a new chemical entity molecular glue that has already achieved IND Candidate status and will be advanced for the treatment of cance
Read at finance.yahoo.com
BeyondSpring Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards BeyondSpring can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
BeyondSpring Fundamental Analysis
We analyze BeyondSpring's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BeyondSpring using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BeyondSpring based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
BeyondSpring is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
BeyondSpring Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BeyondSpring stock to make a market-neutral strategy. Peer analysis of BeyondSpring could also be used in its relative valuation, which is a method of valuing BeyondSpring by comparing valuation metrics with similar companies.
Peers
BeyondSpring Related Equities
FBRX | Forte Biosciences | 18.65 | ||||
SRZN | Surrozen | 8.96 | ||||
ADTX | Aditxt | 7.71 | ||||
CADL | Candel Therapeutics | 7.14 | ||||
ONCT | Oncternal Therapeutics | 5.63 | ||||
MCRB | Seres Therapeutics | 4.55 | ||||
INKT | Mink Therapeutics | 4.35 | ||||
SCPH | Scpharmaceuticals | 3.89 | ||||
RVPH | Reviva Pharmaceuticals | 1.79 | ||||
MIST | Milestone Pharmaceuticals | 1.08 | ||||
PLX | Protalix Biotherapeutics | 0.60 | ||||
EYPT | Eyepoint Pharmaceuticals | 0.56 | ||||
ALVR | Allovir | 1.82 | ||||
ONCY | Oncolytics Biotech | 2.11 | ||||
ARMP | Armata Pharmaceuticals | 2.13 | ||||
SLS | Sellas Life | 2.50 | ||||
KTTA | Pasithea Therapeutics | 3.65 |
Complementary Tools for BeyondSpring Stock analysis
When running BeyondSpring's price analysis, check to measure BeyondSpring's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeyondSpring is operating at the current time. Most of BeyondSpring's value examination focuses on studying past and present price action to predict the probability of BeyondSpring's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeyondSpring's price. Additionally, you may evaluate how the addition of BeyondSpring to your portfolios can decrease your overall portfolio volatility.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |